Glass half empty: Achaogen receives split vote from FDA experts on lead antibiotic, shares plunge
An FDA advisory committee has handed down a split vote — yes for one indication and no for another — on Achaogen’s lead antibiotic, ruffling the high …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
